Extract: Nobel Prize in Physiology or Medicine 2026 (announced 5 October 2026)

• Laureates: Karl Deisseroth (HHMI and Stanford, USA), Peter Hegemann (Humboldt University of Berlin), Georg Nagel (University of Würzburg)
• Citation: discoveries concerning light-gated ion channels and optogenetics
• Prize amount: 12 million SEK, shared equally
• Announced by: Nobel Assembly at Karolinska Institutet (Committee Chair: Per Svenningsson)
• Press contacts: Pernilla Witte and Thomas Perlmann

Who did what

• Hegemann and Nagel: In the early 2000s, they found channelrhodopsin in the single-celled alga Chlamydomonas, which swims toward light. Blue light opens a channel in the protein, ions flow in, and an electrical impulse results. It worked in whatever cell type they put it in.
• Deisseroth: He put the channelrhodopsin gene into rat nerve cells and triggered nerve signals with blue light (published 2005). Two years later, he made the light-controlled switch work in the brains of living mice.

Elaboration

Why it mattered: Earlier brain mapping, such as lesion studies, electrical stimulation and imaging, mostly showed correlation. You could see which regions were involved, but you couldn’t prove causation. Optogenetics lets researchers switch a specific, genetically defined set of neurons on or off, with millisecond precision, and watch what happens to a memory, a mood or a behaviour. That is the causal link the press release says earlier methods lacked.

How it works: Channelrhodopsin is a light-gated cation channel. A virus delivers the gene to chosen cell types, and an implanted fibre-optic delivers blue light. The neuron then fires on command. Related opsins that silence neurons extended the toolkit.

Clinical angle: The release highlights two directions. One is mapping circuits behind neurological and psychiatric disorders. The other is attempts to restore sight in people with visual impairment by making surviving retinal cells light-sensitive.

A point of interest: The discovery came from basic curiosity about how an alga finds light, not from a neuroscience question.

Light-Seeking Algae and the Switch for Nerve Cells

The 2026 Nobel Prize in Physiology or Medicine honours Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries on light-gated ion channels and optogenetics. The prize of 12 million Swedish kronor is shared equally.

A sketch map full of question marks. For decades, neuroscientists could only ask which brain regions were involved in a function. Lesions, electrical stimulation and imaging showed that a region was active or needed, but not that it caused a particular memory, feeling or behaviour. As the Nobel Assembly puts it, the brain’s image was a sketch map full of unknowns. Electrodes also stimulate everything nearby, so they cannot single out one type of cell.

The alga that swims toward light. The answer came from basic curiosity. Peter Hegemann wondered how Chlamydomonas, a single-celled alga, swims toward a light source. In the early 2000s, he and Georg Nagel identified channelrhodopsin, a protein on the cell surface. When blue light hits it, a channel opens through the protein and charged ions flow into the cell, creating an electrical impulse. Crucially, they found that any cell they put the protein into became light sensitive.

From alga to brain. Karl Deisseroth turned this into a tool. He introduced the channelrhodopsin gene into rat nerve cells, and illuminating them with blue light triggered nerve signals. He published this in 2005. Two years later, he made the switch work in the brains of living mice, which showed it could control circuits in a behaving animal.

How it works in practice. Researchers deliver the gene, usually by a harmless virus, to a chosen type of neuron. Light, typically through a thin implanted optical fibre, then switches those neurons on with millisecond precision. Related light-sensitive proteins that silence neurons extend the toolkit, so one cell population can be turned on or off while everything else stays untouched. This gives the causal proof that earlier methods lacked.

Impact. Optogenetics has spread worldwide. It is used to reveal circuits governing specific memories, feelings and behaviours, including those relevant to neurological and psychiatric disorders. In clinical medicine, researchers are using it to try to restore sight in people with visual impairment by making surviving retinal cells light sensitive.

Why it resonates. A tool for understanding the human brain began with an alga’s way of finding sunlight. As Per Svenningsson, Chair of the Nobel Committee, put it, optogenetics offers ways to map the brain “we could once only dream of.”